Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: lined (747)

MyelomaMPVBortezomib(SC)MelphalanPrednisolone(35day)Ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA MPV (SC)-BORTEZOMIB (SC)-MELPHALAN (PO)-PREDNISOLONE (35 day) Regimen Multiple Myeloma – MPV(SC)-Bortezomib (SC)-Melphalan
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPVBortezomibSCMelphalanPrednisolone35dayVer1.pdf

MyelomaMPVBortezomib(IV)MelphalanPrednisolone(35day)Ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA MPV (IV)-BORTEZOMIB (IV)-MELPHALAN (PO)-PREDNISOLONE (35 day) Regimen Multiple Myeloma – MPV(IV)-Bortezomib (IV)-Melphalan
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPVBortezomibIVMelphalanPrednisolone35dayVer1.pdf

Lenalidomide

Description: Chemotherapy Protocol MULTIPLE MYELOMA LENALIDOMIDE Regimen • Multiple Myeloma – Lenalidomide Indication • Lenalidomide is recommended, within its licensed indication, as an option for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Lenalidomide.pdf

Cisplatin-Gemcitabine Version 1.2

Description: Chemotherapy Protocol BILIARY TRACT CANCER CISPLATIN-GEMCITABINE Regimen Biliary Tract Cancer – Cisplatin-Gemcitabine Indication First line therapy of locally advanced / metastatic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Cisplatin-Gemcitabine-Version-12.pdf

InP-Cisplatin(75)-Docetaxel(75)-Fluorouracil(4000)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (75)-DOCETAXEL(75)-FLUOROURACIL(4000) In-Patient Regimen Regimen • Head and Neck Cancer – InP
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin75-Docetaxel75-Fluorouracil4000.pdf

InP-Cisplatin(80)-Docetaxel(40)-Fluorouracil(2800)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (80)-DOCETAXEL(40)-FLUOROURACIL(2800) In-Patient Regimen Regimen • Head and Neck Cancer – InP
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin80-Docetaxel40-Fluorouracil2800.pdf

Cisplatin (75)-Docetaxel(75)-Fluorouracil(4000)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (75)-DOCETAXEL(75)-FLUOROURACIL(4000) Regimen • Head and Neck Cancer – Cisplatin(75)-Docetaxel(75
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-75-Docetaxel75-Fluorouracil4000.pdf

Cetuximab-Radiotherapy (7 day)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CETUXIMAB RT (7 day) Regimen • Head and Neck Cancer – Cetuximab RT (7 day) Indication • Cetuximab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cetuximab-Radiotherapy7day.pdf

Capecitabine-Epirubicin-Oxaliplatin (EOX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, EPIRUBICIN and OXALIPLATIN (EOX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Epirubicin-Oxaliplatin (EOX) Indication • First line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Epirubicin-Oxaliplatin.pdf

Capecitabine-Cisplatin-Epirubicin (ECX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, CISPLATIN and EPIRUBICIN (ECX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Cisplatin-Epirubicin (ECX) Indication • First line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Epirubicin.pdf

371 to 380 of 587

Previous … 36 37 38 39 40 … Next